Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Two athletes follow identical training programs — same volume, same intensity, same recovery protocols, same nutritional targets. One builds muscle at a rate that seems almost effortless. The other struggles to add lean mass despite exceptional discipline. The gap between them is not predominantly effort. It is biology — and a meaningful portion of that biology was determined at conception.

Muscle growth is one of the most genetically variable biological traits in humans. The inherited variants governing satellite cell activation, myosin fiber type composition, anabolic hormone signaling efficiency, and the brake systems that limit muscle hypertrophy create a spectrum of muscular potential so wide that population-average training and nutrition recommendations systematically over-serve some individuals and under-serve others. Understanding your genetic position on that spectrum — before you invest in any muscle growth protocol — is the foundational step that precision exercise science is increasingly demanding.

The PlexusDx Precision Peptide Genetic Test analyzes 15 genetic insights in the Muscle Growth pathway — one of 14 peptide-related biological pathways in the full panel, covering the inherited architecture of your anabolic signaling, fiber type composition, growth hormone pulsatility axis, and myostatin-mediated growth regulation. Here is what your muscle growth genetics actually measure.

The Biology of Muscle Growth: Four Genetic Systems That Determine Your Anabolic Architecture

Skeletal muscle hypertrophy — the increase in muscle fiber cross-sectional area in response to mechanical loading — is not a simple process. It is the emergent outcome of multiple interconnected biological systems operating simultaneously, each with its own genetic variability. Understanding where your inherited profile sits across these systems is the framework for interpreting your Muscle Growth pathway results.

1. IGF1: The Anabolic Master Regulator

Insulin-like growth factor 1 (IGF1) is arguably the most important anabolic signaling molecule in skeletal muscle biology. Produced both systemically by the liver (under growth hormone stimulation) and locally by muscle tissue itself in response to mechanical loading — this locally produced isoform is sometimes called mechano growth factor (MGF) — IGF-1 drives the satellite cell activation, myoblast proliferation, and protein synthesis that collectively produce muscle hypertrophy.

The IGF1 pathway cascade operates through the PI3K/AKT/mTOR signaling axis — the same mTOR system that is central to the Longevity pathway, where its activity is a determinant of the anabolism-versus-autophagy balance that shapes biological aging rate. In muscle, mTOR activation downstream of IGF-1 receptor stimulation is the primary molecular switch that commits a muscle cell to hypertrophic growth rather than maintenance or atrophy mode.

The IGF1 rs35767 promoter polymorphism — a C-to-T substitution in the IGF1 gene promoter — influences baseline IGF-1 transcription levels. The C allele has been associated in multiple research populations with higher circulating IGF-1 concentrations and, in some athletic cohort studies, with enhanced muscle hypertrophic response to resistance training. The underlying mechanism is consistent with a more efficiently transcribed IGF1 promoter producing greater IGF-1 availability for receptor signaling in satellite cells and muscle fibers during the post-exercise recovery window.

The CA repeat microsatellite polymorphism in the IGF1 promoter region (rs35767 is one studied variant within this broader regulatory region) has been associated with differences in IGF-1 levels across multiple cohorts. The 192-bp allele — encoding 19 CA repeats — has been associated in some research populations with higher IGF-1 levels compared to alleles with different repeat lengths, consistent with differences in promoter regulatory efficiency. Understanding your IGF1 genotype provides insight into the inherited efficiency of the primary molecular lever driving your muscle anabolic response to training.

2. MSTN: The Myostatin Brake System

Myostatin (MSTN) encodes myostatin — a member of the TGF-β superfamily that functions as a potent negative regulator of skeletal muscle mass. Its biological role is precisely what its nickname suggests: a brake on muscle growth. Myostatin is produced by skeletal muscle cells and acts in an autocrine/paracrine fashion to limit satellite cell activation, inhibit myoblast differentiation, and suppress the hypertrophic signaling that resistance exercise triggers.

The discovery of MSTN's function came from a remarkable convergence of evidence: loss-of-function mutations in the MSTN gene produce dramatically increased muscle mass in cattle (the Belgian Blue and Piedmontese breeds), mice, and — in rare documented cases — humans. A German child carrying a loss-of-function MSTN mutation displayed extraordinary muscle development from infancy; similar cases have been documented in other populations. These extreme cases established beyond any doubt that myostatin is a genuine biological limiter of muscle mass.

In the non-mutant general population, common variants in and around the MSTN gene influence myostatin expression levels and signaling efficiency — not to the dramatic degree of loss-of-function mutations, but in ways that create measurable differences in baseline muscle growth capacity between individuals. The K153R variant (rs1805086) — a lysine-to-arginine substitution in the myostatin prodomain — has been studied in athletic cohorts for associations with muscle mass, strength performance, and hypertrophic training response. Variants in the MSTN promoter region additionally influence transcriptional regulation of myostatin production, creating differences in the set point of the growth brake between individuals before a single training session occurs.

Understanding your MSTN genotype tells you something fundamental about your inherited muscle growth architecture: how tightly your biology applies the brake on hypertrophic signaling at baseline, and therefore how much anabolic stimulus is required to overcome that baseline inhibition and drive net muscle protein accretion.

3. ACTN3: The Muscle Fiber Type Composition Gene

Alpha-actinin-3 (ACTN3) is a structural protein expressed exclusively in fast-twitch (Type IIx) muscle fibers — the high-force, high-velocity fibers responsible for explosive power output and the primary fibers that hypertrophy in response to resistance training. The ACTN3 rs1815739 variant — the R577X polymorphism — produces a premature stop codon that completely eliminates alpha-actinin-3 protein production in homozygous XX individuals.

The ACTN3 R577X variant is one of the most studied variants in human sports genetics, and its population genetics are striking: approximately 18% of individuals of European ancestry are homozygous XX (completely lacking functional alpha-actinin-3), with carrier frequencies varying significantly across ancestral populations. This makes it one of the most common complete loss-of-function variants in any expressed human gene — a fact that has generated substantial evolutionary biology interest in why a variant eliminating a muscle structural protein has risen to such high frequency.

The functional consequences of ACTN3 genotype for muscle biology are well-established:

  • RR genotype (two R alleles — alpha-actinin-3 present): Fast-twitch fiber structural support intact. Associated in athletic cohort studies with greater explosive power output, higher sprint performance, and — relevant to hypertrophy — more efficient fast-twitch fiber recruitment during high-intensity resistance training. Elite power athletes are significantly enriched for the RR genotype compared to population controls across multiple independent studies.
  • RX genotype (one R allele, one X allele): Reduced alpha-actinin-3 expression. Intermediate phenotype across power and endurance measures. The most common genotype in most European-ancestry populations.
  • XX genotype (no alpha-actinin-3): Fast-twitch fibers compensate with alpha-actinin-2 expression — a structurally similar but functionally distinct protein. XX individuals show a fiber type shift toward more oxidative metabolism, greater endurance capacity relative to power output, and in some studies, a blunted hypertrophic response to maximal-intensity resistance training compared to RR individuals. Elite endurance athletes are enriched for the XX genotype across multiple research cohorts.

Your ACTN3 genotype does not determine whether you can build muscle — it shapes the fiber type composition context in which your training adaptations occur and influences the relative efficiency of power-oriented hypertrophy protocols versus volume-oriented approaches for your specific muscle biology.

4. GHSR: The Growth Hormone Secretagogue Receptor and Pulsatile GH Release

Growth hormone secretagogue receptor (GHSR) encodes the receptor for ghrelin — the primary endogenous growth hormone secretagogue, often called the "hunger hormone" for its appetite-stimulating effects, but equally important as the primary driver of pulsatile growth hormone release from the pituitary gland. The GHSR/ghrelin axis is the most important regulator of GH pulsatility in humans, with ghrelin-stimulated GH pulses — particularly the large nocturnal pulse during deep sleep — being the dominant anabolic GH signal driving IGF-1 production and muscle protein synthesis.

This connection between GHSR and muscle growth biology is direct: ghrelin binds GHSR on pituitary somatotrophs, triggering GH secretion; GH travels to the liver and directly to muscle tissue, stimulating local IGF-1 production; IGF-1 activates the PI3K/AKT/mTOR anabolic cascade in satellite cells and muscle fibers. The GHSR is therefore not a peripheral player in muscle growth biology — it is the upstream receptor that initiates the hormonal cascade governing the amplitude of your body's primary anabolic GH signal.

Variants in the GHSR gene influence receptor expression levels and ghrelin binding efficiency — affecting both the magnitude of GH pulses in response to ghrelin stimulation and the downstream metabolic consequences of GHSR activation, including appetite regulation, energy metabolism, and anabolic signaling amplitude. The intersection of GHSR with both the Muscle Growth pathway and the Weight Management pathway reflects the biological reality that the ghrelin/GHSR system simultaneously governs appetite, energy balance, and anabolic hormone pulsatility — an integrated system that cannot be understood in isolation from either metabolic or muscular biology.

Supporting Cast: The Additional Variants That Complete Your Muscle Growth Profile

IGF1, MSTN, ACTN3, and GHSR are the headline genes in muscle growth genetics — but 15 genetic insights means the Muscle Growth pathway in the PlexusDx panel extends beyond these four anchors. Additional variants relevant to muscle biology include:

  • PPARGC1A (PGC-1α): The master regulator of mitochondrial biogenesis in muscle — governing the oxidative capacity of muscle fibers, endurance adaptation, and the metabolic flexibility that determines whether muscle tissue preferentially burns fat or carbohydrate during exercise. The rs8192678 variant (Gly482Ser) has been studied extensively in the context of training adaptation and muscle metabolic phenotype.
  • VDR (Vitamin D Receptor): Vitamin D receptor variants influence muscle cell differentiation, satellite cell function, and muscle fiber regeneration efficiency — mechanisms through which vitamin D status, mediated by inherited receptor sensitivity, affects muscle development and maintenance across the lifespan.
  • ACE (Angiotensin-Converting Enzyme): The ACE insertion/deletion (I/D) polymorphism affects local renin-angiotensin system activity in muscle tissue, influencing blood flow efficiency during exercise, muscle fiber recruitment patterns, and training adaptation responses. The I allele has been associated with endurance performance advantages; the D allele with power and strength phenotypes in several athletic cohort studies.
  • IL6 (Interleukin-6): IL-6 produced by contracting muscle fibers during exercise functions as a myokine — an exercise signal that drives satellite cell activation, fuel mobilization, and systemic anti-inflammatory responses to training. IL6 promoter variants affect the magnitude of the exercise-induced IL-6 myokine response, with downstream consequences for training adaptation efficiency and post-exercise recovery.

Together, these variants complete a multi-dimensional picture of your inherited muscle growth architecture — one that no single gene can adequately represent, and one that generic training recommendations cannot account for by design.

Why Muscle Growth Pathway Genetics Matter Before Any Peptide-Adjacent Protocol

The muscle growth and anabolic biology space is among the most active areas of peptide research. Growth hormone secretagogue biology, IGF-1 pathway modulation, satellite cell activation, and myostatin inhibition are precisely the molecular targets that sports medicine and performance biology research groups have investigated in the context of peptide-related mechanisms. The GHSR receptor that variants in the PlexusDx panel analyze is the same receptor that the entire growth hormone secretagogue class of research peptides engages — making your GHSR genotype directly relevant context for understanding the biological architecture of your pulsatile GH axis.

What the research has not yet fully resolved — but what precision medicine increasingly demands — is how individual genetic variation across IGF1, MSTN, ACTN3, GHSR, and related genes modifies the biological context in which any muscle support approach operates. A protocol designed to leverage the IGF-1/mTOR anabolic axis operates against a fundamentally different genetic backdrop in someone with high-efficiency IGF1 promoter variants versus someone with lower baseline IGF-1 transcription. A training and recovery protocol designed to maximize hypertrophic response operates differently in an ACTN3 RR individual with intact fast-twitch fiber structure versus an XX individual with compensated fiber type composition.

This genetic context does not tell you what to do. It tells your healthcare provider what your biology is actually doing — the inherited starting point that every muscle growth decision should be calibrated against. Genetics is a guide, not a guarantee. Your MSTN variant does not cap your muscular potential. Your ACTN3 genotype does not prohibit power development. What your genetic profile does is define the biological terrain your training and recovery protocols are operating on — so that every investment you make in your muscle growth biology is matched to your actual inherited architecture rather than a statistical average.

Test before you invest in any muscle growth or anabolic support protocol. Your IGF1 signaling efficiency, your MSTN brake set point, your ACTN3 fiber type composition, and your GHSR pulsatile GH axis architecture are not abstractions. They are the molecular foundation of how your muscles respond to the training and recovery decisions you make every week.

What PlexusDx Analyzes in the Muscle Growth Pathway

The Muscle Growth pathway in the PlexusDx Precision Peptide Genetic Test includes 15 genetic insights — placing it third in the panel by insight count, behind Weight Management (33) and Longevity & Aging (17), and ahead of Skin Health (14) — reflecting the depth of genetic research connecting inherited variation to muscle biology and anabolic signaling architecture.

The 15 Muscle Growth insights sit within a full panel analyzing 48 unique genes and 57 unique SNPs, delivering 150 total genetic insights across all 14 pathways. All samples are processed on the Illumina Global Screening Array in CLIA-certified laboratories. Results are delivered through the Peptide Pathways Report in the PlexusDx Results Portal, where each Muscle Growth insight is presented with your personal genotype context and educational framing designed to inform a precision conversation with your healthcare provider, sports medicine specialist, or performance practitioner.

The Muscle Growth pathway results gain additional interpretive depth when viewed alongside the Tissue Repair pathway (9 insights governing connective tissue remodeling and recovery), the Energy Metabolism pathway (12 insights governing substrate utilization and mitochondrial efficiency), and the Longevity & Aging pathway (17 insights including mTOR signaling architecture that directly intersects with the IGF-1/mTOR hypertrophy cascade). Muscle biology does not operate in isolation — it is embedded in a systemic biological context that the full 14-pathway panel maps simultaneously.

Who Should Know Their Muscle Growth Genetic Profile

  • Strength athletes, bodybuilders, and resistance training practitioners who want to understand the inherited anabolic architecture their training program is operating on — so that programming decisions are calibrated to their actual fiber type composition, satellite cell signaling efficiency, and myostatin brake set point
  • Endurance athletes incorporating strength and hypertrophy work into a performance framework who want to understand how their ACTN3 genotype and metabolic genetics interact with power-oriented training adaptations
  • Healthcare providers, sports medicine specialists, and performance coaches building genotype-informed training and recovery protocols for athletes and fitness practitioners seeking precision approaches to muscle development
  • Individuals who have experienced inconsistent or disappointing results from resistance training and recovery protocols and want to understand whether inherited biological factors — IGF1 signaling efficiency, MSTN brake activity, or ACTN3 fiber type composition — may explain that variability
  • Longevity-focused individuals tracking muscle mass preservation as a marker of healthy aging and metabolic resilience, given the well-established relationship between skeletal muscle mass, insulin sensitivity, and long-term healthspan outcomes
  • Biohackers and precision health practitioners building a genetics-first framework for physical performance optimization — using inherited pathway data to guide training design, recovery strategy, and nutritional investment decisions

Already Have a PlexusDx Genetic Profile on File?

If you have previously completed a PlexusDx genetic test, your DNA data is already on file. The Peptide Pathways Report is available as a standalone add-on — delivering all 15 Muscle Growth genetic insights alongside the complete 150-insight, 14-pathway panel, with no new sample required. Your IGF1 anabolic signaling architecture, MSTN brake set point, ACTN3 fiber type composition profile, GHSR pulsatile GH axis genetics, and 11 additional Muscle Growth insights — unlocked from your existing genetic data.

Frequently Asked Questions About Muscle Growth Genetics

What does my ACTN3 genotype actually mean for my muscle growth potential?

Your ACTN3 R577X genotype tells you about the structural composition of your fast-twitch muscle fibers. RR individuals have intact alpha-actinin-3 in Type IIx fibers, supporting more efficient fast-twitch recruitment and explosive power output during high-intensity training. XX individuals — who completely lack alpha-actinin-3 — show a fiber type shift toward more oxidative metabolism, which may favor volume-based hypertrophy approaches over maximal-intensity protocols. No ACTN3 genotype eliminates muscle growth potential. Genetics is a guide, not a guarantee.

Does the PlexusDx Precision Peptide Genetic Test tell me which muscle growth or anabolic support protocols are right for me?

No. The test analyzes how your genes influence peptide-related biological pathways, including 15 Muscle Growth genetic insights covering IGF-1 signaling (IGF1), myostatin regulation (MSTN), fiber type composition (ACTN3), and growth hormone secretagogue receptor biology (GHSR). It does not recommend, prescribe, or determine which peptides or interventions to use. Your results give your healthcare provider or sports medicine specialist the genetic baseline for a precision muscle protocol. Always consult a qualified healthcare provider before beginning any peptide or performance protocol.

How many genetic insights are in the Muscle Growth pathway, and what does the full panel cover?

The Muscle Growth pathway includes 15 genetic insights — third among 14 peptide-related biological pathways, behind Weight Management (33) and Longevity & Aging (17). The full panel analyzes 48 unique genes and 57 unique SNPs, delivering 150 total genetic insights across weight management, longevity, muscle growth, skin health, energy metabolism, immunity, tissue repair, mood, cognition, inflammation, reproductive health, sexual health, brain health, and sleep. All samples are processed on the Illumina Global Screening Array in CLIA-certified laboratories.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to understand your muscle growth genetics — IGF1, MSTN, ACTN3, GHSR, and 11 more anabolic biology insights?

👉 Get the Precision Peptide Genetic Test — 14 pathways, 49 unique peptides analyzed, 150 genetic insights, processed on the Illumina Global Screening Array in a CLIA-certified laboratory.

👉 Already tested? Add the Peptide Pathways Report — no new sample required. Unlock your complete Muscle Growth pathway results — all 15 genetic insights — from your existing PlexusDx genetic data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.